Effect of Hepatic Impairment on LDK378 Pharmacokinetics

Clinical trial NCT01950481 · COMPLETED

Trial details

NCT number: NCT01950481
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Normal Hepatic Function Impaired Hepatic Function

Start date: 2014-01-01
Primary completion: 2016-09-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.